跳至主要内容
临床试验/ISRCTN95281775
ISRCTN95281775已完成未知

The influence of a novel, ready-to-drink whey protein beverage on appetite, postprandial glycaemia and gastric emptying in lean and centrally obese adults

ewcastle University0 个研究点目标入组 25 人开始时间: 2019年8月2日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
25

研究概览

简要总结

2019 Other publications in https://doi.org/10.2337/db19-2276-PUB K. Smith., Taylor. G.S., Okwose, N., Allerton, D.M., Brunsgaard, L.H., Stevenson, E.J. & West, D.W. (). 2276-PUB: A Palatable, Novel Whey Protein Shot Attenuates Postprandial Glycemia in Lean and Centrally Obese Adult Males, Diabetes. 68 (supplement 1). 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34220720/ (added 06/07/2021) 2024 Other publications in https://pubmed.ncbi.nlm.nih.gov/39138690/ secondary analysis (added 15/08/2024)

研究设计

研究类型
Interventional

入排标准

性别
Male

入选标准

  • 1. Aged between 18 – 65 years
  • 2. BMI of 18 - 25 kg.m2
  • 3. Weight stable for > 2 months (± 1kg) preceding the commencement of the intervention
  • 4. Physically active as assessed by the International Physical Activity Questionnaire
  • 5. Adhere to a normal wake/sleep cycle (i.e. non-shift workers)
  • 6. Regularly consume breakfast
  • Centrally obese:
  • 1. Aged between 18 – 65 years
  • 2. BMI > 30 kg.m2 or waist circumference of > 102 cm
  • 3. Weight stable for > 2 months (± 1kg) preceding the commencement of the intervention
  • 4. Physical inactive as assessed by the International Physical Activity Questionnaire
  • 5. Adhere to a normal wake/sleep cycle (i.e. non-shift workers)
  • 6. Regularly consume breakfast

排除标准

  • 1. History of metabolic or cardiovascular diseases
  • 2. Taking medicines that may influence gut function or satiety
  • 3. Smokers
  • 4. Gastrointestinal issues
  • 5. Known food intolerance's or allergies
  • 6. Substance abuse

研究者

发起方
ewcastle University

相似试验